Exosome RNA Exosome RNA Research & Industry News

Extracellular vesicles (EVs) are esteemed as a promising delivery vehicle for various genetic therapeutics. They are relatively inert, non-immunogenic, biodegradable, and biocompatible...

VivaZome Therapeutics is delighted to announce that it has been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the...

Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint...

Aberrant Wnt activation has been reported in failing cardiomyocytes. Researchers at University Medical Center Göttingen present single cell transcriptome profiling of hearts with inducible cardiomyocyte-specific Wnt activation (β-catΔex3) as well as with...

In a series of three papers on extracellular vesicles (EVs) — particles that cells use to communicate — Skoltech researchers and their colleagues have...

Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy can be used to assess the effectivity of spike-neutralizing antibodies for preventing COVID-19. The use of...

Exosomes RNA are pleased to announce that we are an official media partner of Applications of Exosomes. Returning for another year on March 29-30, 2023, this hugely successful 2-day digital...

The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Miguel Flores-Bellver, PhD, recipient of the 2023 Bert M. Glaser, MD Award for Innovative Research in...

Despite significant therapeutic advances, lung cancer remains the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) patients have a very poor overall five-year survival rate of...

Micro ribonucleic acids (miRNAs) in exosomes have been proven as reliable biomarkers to detect disease progression. In recent years, deoxyribonucleic acid...